Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 194 | 37 | 1,392 | 663 | 168 |
| Cost of Goods | 101 | N/A | 1,413 | 494 | 197 |
| Gross Profit | 93 | 37 | -21 | 169 | -29 |
| Operating Expenses | 3,927 | 2,975 | 3,433 | 3,674 | 3,672 |
| Operating Income | -3,733 | -2,938 | -3,041 | -3,011 | -3,504 |
| Other Income | 3,939 | -1,973 | -2,721 | -45 | 669 |
| Pre-tax Income | 206 | -4,911 | -5,762 | -3,056 | -2,835 |
| Income Tax | N/A | N/A | -636 | -547 | -233 |
| Net Income Continuous | 206 | -4,911 | -5,126 | -2,509 | -2,602 |
| Net Income | $206 | $-4,911 | $-5,126 | $-2,509 | $-2,602 |
| EPS Basic Total Ops | 1.00 | -30.00 | -32.00 | -15.00 | -16.00 |
| EPS Basic Continuous Ops | 1.24 | -29.87 | -31.18 | -15.26 | -15.83 |
| EPS Diluted Total Ops | 1.00 | -30.00 | -32.00 | -15.00 | -16.00 |
| EPS Diluted Continuous Ops | 1.19 | -29.87 | -31.79 | -15.26 | -15.83 |
| EBITDA(a) | $-3,681 | $-2,890 | $-3,098 | $N/A | $-3,483 |